DTU Nanotech spinout company specialising in cancer treatment receives significant funding

Tuesday 14 Mar 17


Simon Skjøde Jensen
DTU Nanotech

The DTU Nanotech spinout company Monta Biosciences has succeeded in attracting a 2 MDKK investment from Pre-seed Innovation. Managing director Simon Skjøde Jensen says that the investment will make it possible for Monta Biosciences to reach milestones and goals which will strengthen our technology and ultimately make it possible to attract further investment and potentially enter partnerships with pharma companies.

The technology developed by Monta Biosciences aims at training the body’s immune system in recognising and combating cancer cells.

Read more here (in Danish)